| Natasha Evon Mcgill, LPN | |
|
12958 High Crest St, Black Jack, MO 63033-4552 | |
| (314) 258-1268 | |
| Not Available |
| Full Name | Natasha Evon Mcgill |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 12958 High Crest St, Black Jack, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336795061 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 2016003867 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Natasha Evon Mcgill, LPN 12958 High Crest St, Black Jack, MO 63033-4552 Ph: (314) 258-1268 | Natasha Evon Mcgill, LPN 12958 High Crest St, Black Jack, MO 63033-4552 Ph: (314) 258-1268 |
News Archive
One of the most challenging issues in stroke care involves the use of clot-busting drugs such as tPA. When given quickly enough and to the right patient, such drugs can minimize stroke damage by dissolving blood clots that cause most strokes. But these blood-thinning drugs also increase the risk of brain hemorrhages and other complications.
ReVision Optics, a leading company in the research, development and manufacture of implantable medical devices designed to assist patients that need reading glasses, announced today that it has completed enrollment and initial follow up in Phase I of its US clinical trial and has filed for expansion. The clinical trial is for the study of the PresbyLens, recently renamed Vue+, for the improvement of near vision in patients with presbyopia, the age-related loss of near vision.
The Joint Center for Cancer Precision Medicine, a collaborative initiative among Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston Children's Hospital, and the Broad Institute of MIT and Harvard, has been established to create "precision medicine treatment pathways" for patients with advanced cancers and to speed the development of personalized therapies.
University of Georgia scientists have discovered a new flu-fighting role for a well-known component of the immune system. Kimberly Klonowski, assistant professor of cellular biology in the UGA Franklin College of Arts and Sciences, and her colleagues found that administering a cell-signaling protein known as IL-15 to mice infected with influenza reduces their peak viral load by nearly three times.
A blind man's sight-restoring operation was broadcast live around the world at 1.30pm (BST) today from a hospital in Malawi.
› Verified 2 days ago